(Q33696756)

28 July 2017

1 reference

title

Differences and similarities between chronic obstructive pulmonary disease and asthma (English)

1 reference

chronic obstructive pulmonary disease

28 July 2017

1 reference

1 reference

Jeffery PK

1

1 reference

28 July 2017

1 June 1999

1 reference

Clinical & Experimental Allergy

28 July 2017

1 reference

28 July 2017

29 Suppl 2

1 reference

28 July 2017

14-26

1 reference

Torsades de pointes occurring in association with terfenadine use

28 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

Comparative effects of loratadine and terfenadine on cardiac K+ channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

Relations of QTc prolongation on the electrocardiogram to torsades de pointes: definitions and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

Measurement of the QT interval and the risk associated with QTc interval prolongation: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

How to measure the QT interval--what is normal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

Rate-corrected QT interval: techniques and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

Mechanism of the cardiotoxic actions of terfenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

Non-sedating antihistamines and cardiac arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

Which cardiac potassium channel subtype is the preferable target for suppression of ventricular arrhythmias?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

Population pharmacokinetics of terfenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

Risks of non-sedating antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

Dangers of non-sedating antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

Dangers of non-sedating antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: distinguishing a drug effect from spontaneous variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00004.X

10.1046/J.1365-2222.1999.00004.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10421818